サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1347565

ニューロモデュレーション市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Neuromodulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 141 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ニューロモデュレーション市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界のニューロモデュレーション市場規模は2022年に67億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて10.4%の成長率（CAGR）を示し、2028年までに125億米ドルに達すると予測しています。

ニューロモデュレーションは、電気的または薬学的薬剤を標的部位に直接送達することにより、神経活動を調節・変化させるために用いられる医療技術です。患者の神経活動を補うために、パルス発生器の助けを借りて電気刺激を発生させる小さな電極で構成されています。電極は一般に神経、脳、脊髄に設置され、パルスジェネレーターは皮膚内に埋め込まれます。ニューロモデュレーションはうつ病、慢性疼痛、てんかん、振戦、片頭痛、腰痛症、パーキンソン病、胃不全麻痺などの治療に広く用いられています。迷走神経、脳深部、経頭蓋磁気、電気刺激などが含まれます。神経活動のモニタリング、症状の緩和、脳内活動レベルの正常化を支援します。

ニューロモデュレーション市場の動向：

老年人口の増加、アルツハイマー病やパーキンソン病の世界の有病率の増加が市場成長を促進する主な要因です。ニューロモデュレーションは、過活動膀胱、動作低下、硬直、振戦、歩行障害、神経変性、神経学的障害の治療に広く使用されています。さらに、高エネルギー密度、再充電可能性、強化されたサイクル温度を提供するリチウムイオン（Li-ion）電池の導入などの技術革新が、市場成長を大幅に後押ししています。さらに、複合性局所疼痛症候群、神経障害、神経損傷、腰部手術失敗症候群、クモ膜炎など、さまざまな医療問題における脊髄刺激（SCS）の広範な利用が、市場成長にプラスの影響を与えています。これとは別に、低バイポーラまたはモノポーラの電気インパルスを供給し、うつ病や強迫性障害（OCD）の治療に使用される脳深部刺激（DBS）の利用が増加していることが、市場に明るい見通しを生み出しています。その他の要因としては、広範な研究開発（R&D）活動やヘルスケア産業の著しい成長などが挙げられ、市場の成長に向けた原動力になると予想されます。

本レポートで扱う主な質問

  • 世界のニューロモデュレーション市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界のニューロモデュレーション市場に与えた影響は？
  • 主要な地域市場は？
  • 技術別の市場内訳は？
  • バイオマテリアルに基づく市場内訳は？
  • 用途別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界のニューロモデュレーション市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 ニューロモデュレーションの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：技術別

  • 体内ニューロモデュレーション
    • 市場動向
    • 主要セグメント
      • 脊髄刺激（SCS）
      • 脳深部刺激療法（DBS）
      • 迷走神経刺激（VNS）
      • 仙骨神経刺激（SNS）
      • 胃電気刺激（GES）
    • 市場予測
  • 体外ニューロモデュレーション
    • 市場動向
    • 主要セグメント
      • 経皮的電気神経刺激（TENS）
      • 経頭蓋磁気刺激（TMS）
      • その他
    • 市場予測

第7章 市場内訳：バイオマテリアル別

  • 金属バイオマテリアル
    • 市場動向
    • 市場予測
  • 高分子バイオマテリアル
    • 市場動向
    • 市場予測
  • セラミックバイオマテリアル
    • 市場動向
    • 市場展望

第8章 市場内訳：用途別

  • パーキンソン病
    • 市場動向
    • 市場予測
  • てんかん
    • 市場動向
    • 市場予測
  • うつ病
    • 市場動向
    • 市場予測
  • ジストニア
    • 市場動向
    • 市場予測
  • 疼痛管理
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Bioventus Inc.
    • Boston Scientific Corporation
    • Helius Medical Technologies
    • Integer Holdings Corporation
    • LivaNova PLC
    • Medtronic plc
    • MicroTransponder Inc.
    • Neuronetics
    • NeuroPace Inc.
    • NeuroSigma Inc.
    • Nevro Corp.
図表

List of Figures

  • Figure 1: Global: Neuromodulation Market: Major Drivers and Challenges
  • Figure 2: Global: Neuromodulation Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Neuromodulation Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Neuromodulation Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Neuromodulation Market: Breakup by Biomaterial (in %), 2022
  • Figure 6: Global: Neuromodulation Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Neuromodulation Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Neuromodulation (Internal Neuromodulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Neuromodulation (Internal Neuromodulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Neuromodulation (External Neuromodulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Neuromodulation (External Neuromodulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Neuromodulation (Metallic Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Neuromodulation (Metallic Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Neuromodulation (Polymeric Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Neuromodulation (Polymeric Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Neuromodulation (Ceramic Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Neuromodulation (Ceramic Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Neuromodulation (Parkinson's Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Neuromodulation (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Neuromodulation (Epilepsy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Neuromodulation (Epilepsy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Neuromodulation (Depression) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Neuromodulation (Depression) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Neuromodulation (Dystonia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Neuromodulation (Dystonia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Neuromodulation (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Neuromodulation (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Neuromodulation (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Neuromodulation (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Neuromodulation Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Neuromodulation Industry: SWOT Analysis
  • Figure 80: Global: Neuromodulation Industry: Value Chain Analysis
  • Figure 81: Global: Neuromodulation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neuromodulation Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Neuromodulation Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 3: Global: Neuromodulation Market Forecast: Breakup by Biomaterial (in Million US$), 2023-2028
  • Table 4: Global: Neuromodulation Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Neuromodulation Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Neuromodulation Market: Competitive Structure
  • Table 7: Global: Neuromodulation Market: Key Players
目次
Product Code: SR112023A5722

Market Overview:

The global neuromodulation market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.5 Billion by 2028, exhibiting a growth rate (CAGR) of 10.4% during 2023-2028.

Neuromodulation is a medical technique used for the modulation and alteration of nerve activities by delivering electrical or pharmaceutical agents directly to the targeted area. It consists of tiny electrodes that generate electrical stimulation with the help of pulse generators to supplement neurological activities in the patients. The electrodes are generally placed in the nerves, brain, or spinal cord, whereas pulse generators are implanted within the skin. Neuromodulation is widely used to treat depression, chronic pain, epilepsy, tremor, migraine, failed back syndrome, Parkinson's disease, and gastroparesis. It includes the vagal nerve, deep brain, transcranial magnetic, and electrical stimulation. It assists in monitoring nerve activity, alleviating symptoms, and normalizing activity levels in the brain.

Neuromodulation Market Trends:

The rising geriatric population and the increasing prevalence of Alzheimer's and Parkinson's diseases across the globe are key factors driving the market growth. Neuromodulation is widely used to treat overactive bladder, low movement, rigidity, tremor, walking problems, neurodegenerative, and neurological disorders. Moreover, technological innovations, such as the introduction of lithium-ion (Li-ion) batteries that provide high energy density, rechargeability, and enhanced cycling temperature, are providing a considerable boost to the market growth. Additionally, the widespread utilization of spinal cord stimulation (SCS) in various medical problems, such as complex regional pain syndrome, neuropathy, nerve damage, failed-back surgery syndrome, and arachnoiditis, is positively impacting the market growth. Apart from this, the increasing usage of deep brain stimulation (DBS) that delivers low bipolar or monopolar electric impulses and is used in the treatment of depression and obsessive-compulsive disorders (OCD) is creating a positive outlook for the market. Other factors, such as extensive research and development (R&D) activities and significant growth in the healthcare industry, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neuromodulation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technology, biomaterial and application.

Breakup by Technology:

Internal Neuromodulation

Spinal Cord Stimulation (SCS)

Deep Brain Stimulation (DBS)

Vagus Nerve Stimulation (VNS)

Sacral Nerve Stimulation (SNS)

Gastric Electrical Stimulation (GES)

External Neuromodulation

Transcutaneous Electrical Nerve Stimulation (TENS)

Transcranial Magnetic Stimulation (TMS)

Others

Breakup by Biomaterial:

Metallic Biomaterials

Polymeric Biomaterials

Ceramic Biomaterials

Breakup by Application:

Parkinson's Disease

Epilepsy

Depression

Dystonia

Pain Management

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bioventus Inc., Boston Scientific Corporation, Helius Medical Technologies, Integer Holdings Corporation, LivaNova PLC, Medtronic plc, MicroTransponder Inc., Neuronetics, NeuroPace Inc., NeuroSigma Inc., Nevro Corp.

Key Questions Answered in This Report:

  • How has the global neuromodulation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global neuromodulation market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the biomaterial?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global neuromodulation market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neuromodulation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Internal Neuromodulation
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Spinal Cord Stimulation (SCS)
      • 6.1.2.2 Deep Brain Stimulation (DBS)
      • 6.1.2.3 Vagus Nerve Stimulation (VNS)
      • 6.1.2.4 Sacral Nerve Stimulation (SNS)
      • 6.1.2.5 Gastric Electrical Stimulation (GES)
    • 6.1.3 Market Forecast
  • 6.2 External Neuromodulation
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 6.2.2.2 Transcranial Magnetic Stimulation (TMS)
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Biomaterial

  • 7.1 Metallic Biomaterials
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymeric Biomaterials
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ceramic Biomaterials
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Parkinson's Disease
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Epilepsy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Depression
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Dystonia
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Pain Management
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bioventus Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Boston Scientific Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Helius Medical Technologies
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Integer Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 LivaNova PLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 MicroTransponder Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Neuronetics
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 NeuroPace Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 NeuroSigma Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Nevro Corp.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials